Unknown PHASE2 INTERVENTIONAL 1-arm NCT00834301

An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients

Sponsor: Nephrian

Conditions Hyperphosphatemia Inflammation Renal Disease

Updated 5 times since 2017 Last updated: Feb 2, 2009 Started: Jan 31, 2009 Primary completion: Sep 30, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Hyperphosphatemia and Inflammation, this trial is ongoing. The trial is conducted by Nephrian and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Feb 2017 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nephrian

Data source: Nephrian

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Simi Valley, United States